PTT Global Chemical and Japanese Firms Jointly Pursue Thai PO/Polyols Complex

Thai chemical company PTT Global Chemical (PTTGC) has signed two agreements with Japanese firms Toyota Tsusho and Sanyo Chemical Industries (SCI) to jointly carry out engineering studies for a propylene oxide (PO) and polyether polyols complex.

A total investment of around $1 billion will be made in the plants which will be located on the Hemaraj Eastern Industrial Estate in Rayong. Toyoto Tsusho will partner PTTGC to study a 200,000 t/y PO plant, with Sanyo Chemical Industries joining for the study on a 130,000 t/y polyols facility.

The engineering work follows the successful completion of a preliminary joint feasibility study which began early this year. Front end engineering design (FEED) and verification of the project’s viability will now take place before a final investment decision is made, targeted for 2016, when the next phase of engineering, procurement and construction will proceed.

PTTGC said that it would secure a reliable and stable supply of propylene and ethylene oxide feedstock, while SCI will provide its technology know-how and R&D development on polyols.

Toyota Tsucho, a trading company owned 21.7% by Toyota Motor Corporation, will provide logistics and order management expertise from its strong market and global sales network, particularly in India and Asia-Pacific for both PO and polyols.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

most read

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.